The clinical value of thyroid hormones in predicting recurrent atrial fibrillation after catheter ablation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042482

Enrollment

Unknown

Registered

2021-01-22

Start date

2021-01-20

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with indications for catheter ablation of atrial fibrillation in accordance with the European heart disease guidelines 2020.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of catheter ablation; 2. Patients with left atrial thrombosis; 3. Patients with contraindication of anticoagulation; 4. Patients with ablation failure; 5. patients who refused the study.

Design outcomes

Primary

Measure	Time frame
recurrent atrial fibrillation;	—

Countries

China

Contacts

Public ContactLing Yang

Changzhou First People's Hospital (the Third Affiliated Hospital of Suzhou University)

linda_yl@sina.com+86 13616110633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026